Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hospira, Inc., A Pfizer Company
FDA Inspection
•Hospira, Inc., A Pfizer Company•January 17, 2020

Hospira, Inc., A Pfizer Company – FDA Inspection, Jan 17, 2020

Record Details

This FDA Inspection record concerns Hospira, Inc., A Pfizer Company, with an inspection on January 17, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Hospira, Inc., A Pfizer Company
Inspection Date
January 17, 2020
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 39385f66-71df-45ae-876a-f6026e6f413f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1115467
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 211.165(d)Acceptance criteria for sampling & testing
  2. 21 CFR 211.46(c)Exhaust systems inadequate to control air contamination
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
  5. 21 CFR 211.113(b)Validation lacking for sterile drug products
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.22(d)Procedures not in writing, fully followed
  8. 21 CFR 211.100(b)SOPs not followed / documented
  9. 21 CFR 211.192Written record of investigation incomplete
  10. 21 CFR 211.110(b)In-process conformity - examination, sample testing

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hospira, Inc., A Pfizer Company

19
DateClassificationOfficeProject area
March 10, 2026Not classifiedKansas City District Office
January 17, 2025VAIKansas City District OfficeDrug Quality Assurance
March 27, 2024NAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
June 30, 2023Not classifiedKansas City District Office
August 15, 2018OAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
View all 19 other inspections on the company page
Other documents for Hospira, Inc., A Pfizer Company
  • FDA Inspection 1310592 - 2026-03-10
  • FDA Inspection 1255699 - 2025-01-17
  • FDA Inspection 1229140 - 2024-03-27
  • FDA Inspection 1209308 - 2023-06-30
  • FDA Inspection 1064827 - 2018-08-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira, Inc., A Pfizer Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.